Embolization of Arteriovenous Malformations with Onyx: Clinicopathological Experience in 23 Patients

Abstract
OBJECTIVE. To report our experience in treatment of arteriovenous malformations (AVMs) using a new liquid embolic agent, Onyx (Micro Therapeutics, Inc.